Selecting the Optimum First-line Treatment for H. pylori Eradication

被引：1
|
作者：
Ang, Tiing L. [1 ]
Almadi, Majid A. [2 ,3 ]
机构：
[1] Changi Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[2] King Saud Univ, King Khalid Univ Hosp, Div Gastroenterol, Dept Med, Riyadh, Saudi Arabia
[3] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada
来源：
SAUDI JOURNAL OF GASTROENTEROLOGY | 2015年 / 21卷 / 04期
关键词：
STANDARD TRIPLE THERAPY; SEQUENTIAL THERAPY; INFECTION; METAANALYSIS; RESISTANCE; EFFICACY; RATES;
D O I：
10.4103/1319-3767.161638
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [21] Comparison of Standard, Sequential, and Concomitant First Line Eradication Therapy for H. pylori
    Park, Eun Hyea
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S678 - S678
  • [22] First-line H. pylori eradication therapy in Europe: Results from 24,882 cases of the European Registry on H. pylori Management (Hp-EuReg)
    Nyssen, O. P.
    Bordin, D.
    Tepes, B.
    Perez-Aisa, A.
    Vaira, D.
    Caldas, M.
    Bujanda, L.
    Castro-Fernandez, M.
    Lerang, F. Frode
    Leja, M.
    Rodrigo, L.
    Rokkas, T.
    Kupcinskas, L.
    Perez-Lasala, J.
    Jonaitis, L.
    Shvets, O.
    Gasbarrini, A.
    Simsek, H.
    Axon, A. T. R.
    Buzas, G. M.
    Machado, J.
    Niv, Y.
    Boyanova, L.
    Goldis, A.
    Lamy, V.
    Tonkic, A.
    Przytulski, K.
    Beglinger, C.
    Venerito, M.
    Bytzer, P.
    Capelle, L. G.
    Milosavljevic, T.
    Milivojevic, V.
    Veijola, L.
    Molina-Infante, J.
    Vologzhanina, L.
    Fadeenko, G.
    Arino, I.
    Fiorini, G.
    Garre, A.
    Garrido, J.
    Perez, C. F.
    Heluwaert, F.
    Puig, I.
    Megraud, F.
    O'Morain, C.
    Gisbert, J. P.
    HELICOBACTER, 2020, 25 : 12 - 13
  • [23] Effectiveness of first-line H. pylori eradication therapy according to the daily statin-use: Analysis of the European Registry on H. pylori Management (Hp-EuReg)
    Caldas, M.
    Perez-Aisa, A.
    Tepes, B.
    Castro-Fernandez, M.
    Bujanda, L.
    Fadeenko, G.
    Lucendo, A. J.
    Vaira, D.
    Jonaitis, L.
    Brglez Jurecic, N.
    Perez-Lasala, J.
    Fernandez-Salazar, L.
    Rodrigo, L.
    Huguet, J.
    Leja, M.
    Areia, M.
    Barrio, J.
    Ortuno, J.
    Alekseenko, S.
    Molina-Infante, J.
    Bogomolov, P.
    Ntouli, V.
    Dominguez-Cajal, M.
    Ruiz-Zorrilla, R.
    Pellicano, R.
    Espada, M.
    Puig, I.
    Nyssen, O. P.
    Megraud, F.
    O'Morain, C.
    Gisbert, J. P.
    HELICOBACTER, 2020, 25 : 36 - 37
  • [24] First-line H. pylori eradication therapy in Europe: Results from 21,487 cases of the European Registry on H. pylori Management (Hp-EuReg)
    McNicholl, A. G.
    Nyssen, O. P.
    Bordin, D. S.
    Tepes, B.
    Perez-Aisa, A.
    Vaira, D.
    Caldas, M.
    Bujanda, L.
    Castro-Fernandez, M.
    Lerang, F.
    Leja, M.
    Rodrigo, L.
    Rokkas, T.
    Kupcinskas, L.
    Perez-Lasala, J.
    Jonaitis, L. V.
    Shvets, O.
    Gasbarrini, A.
    Simsek, H.
    Axon, A. T. R.
    Buzas, G. M.
    Machado, J. C.
    Niv, Y.
    Boyanova, L.
    Goldis, A.
    Lamy, V.
    Katicic, M.
    Przytulski, K.
    Beglinger, C.
    Venerito, M.
    Bytzer, P.
    Capelle, L. G.
    Milosavljevic, T.
    Veijola, L. I.
    Molina-Infante, J.
    Vologhzanina, L.
    Fadeenko, G.
    Arino, I.
    Fiorini, G.
    Ramas, M.
    Donday, M. G.
    Megraud, F.
    O'Morain, C.
    Gisbert, J. P.
    HELICOBACTER, 2019, 24
  • [25] Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinical practice
    Fiorini, G.
    Zullo, A.
    Saracino, I. M.
    Gatta, L.
    Pavoni, M.
    Vaira, D.
    HELICOBACTER, 2018, 23
  • [26] PYLERA AND SEQUENTIAL THERAPY FOR FIRST-LINE H. PYLORI ERADICATION: A CULTURE-BASED STUDY IN REAL CLINICAL PRACTICE
    Fiorini, G.
    Zullo, A.
    Saracino, I. M.
    Gatta, L.
    Pavoni, M.
    Vaira, B.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E105 - E105
  • [27] 14 DAY-SEQUENTIAL, CONCOMITANT, AND HYBRID THERAPIES FOR FIRST-LINE HELICOBACTER PYLORI (H. PYLORI) ERADICATION: A NETWORK META-ANALYSIS
    Zhao, X.
    Wu, W.
    VALUE IN HEALTH, 2015, 18 (03) : A222 - A222
  • [28] H. pylori First-Line Treatment and Levofloxacin-Based Rescue Option in Patients Allergic to Penicillin
    Gisbert, J. P.
    Perez-Aisa, A.
    Castro-Fernandez, M.
    Barrio, J.
    Rodrigo, L.
    Cosme, A.
    Gisbert, J. L.
    Marcos, S.
    Moreno-Otero, R.
    HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [29] Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment
    Sacco, F.
    Spezzaferro, M.
    Amitrano, M.
    Grossi, L.
    Manzoli, L.
    Marzio, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (02) : 110 - 114
  • [30] Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication
    De Francesco, Vincenzo
    Ridola, Lorenzo
    Hassan, Cesare
    Bellesia, Annamaria
    Alvaro, Domenico
    Vaira, Dino
    Zullo, Angelo
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (02) : 147 - 150
12345